trending Market Intelligence /marketintelligence/en/news-insights/trending/-4alJFhpgPzWg2D38_UmYQ2 content esgSubNav
In This List

Protagonist Therapeutics names board member

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


Protagonist Therapeutics names board member

Protagonist Therapeutics Inc. appointed Bryan Giraudo to its board.

Giraudo also serves as CFO of Gossamer Bio Inc. Previously, he worked at Leerink Partners as senior managing director, in charge of western North America and Asia biotechnology and pharmaceutical relationships.

Protagonist Therapeutics is a Newark, Calif.-based biopharmaceutical company, whose product pipeline includes therapies for inflammatory bowel diseases such as ulcerative colitis and Crohn's disease.